Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT01488929
Safety study of Efficacy, Safety, and Tolerability of TC-5619 in schizophrenia
This study is completed in the United States, in Hungary, in Romania, .... It is testing Efficacy, Safety, and Tolerability of TC-5619 for schizophrenia.
Schizophrenia, Negative Symptoms, ...DrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateDecember 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 603
- Sponsor
- Targacept Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Hungary, Romania, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01488929
- Official title
- A Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Assess Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01488929. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Hungary · 5 sites
- Semmelweis University, Department of PsychiatryBudapestSite status: Not listed — confirm with the team
- University of Debrecen, Medical and Health Science Centre, Department of PsychiatryDebrecenSite status: Not listed — confirm with the team
- Pharma4Trial Kft.GyöngyösSite status: Not listed — confirm with the team
- University of Pecs, Department of PsychiatryPécsSite status: Not listed — confirm with the team
- St. George Hospital, Department of PsychiatrySzékesfehérvárSite status: Not listed — confirm with the team
Romania · 5 sites
- County Emergency Clinical Hospital of AradArad, AradSite status: Not listed — confirm with the team
- CMDTA NeomedBrasov, Brașov CountySite status: Not listed — confirm with the team
- Neuropsychiatry Clinical Hospital Craiova, Psychiatry DepartmentCraiova, DoljSite status: Not listed — confirm with the team
- SC Lorentina 2102 SRLTargoviste, Dâmbovița CountySite status: Not listed — confirm with the team
- University Emergency Central Military Hospital, Dept. of PsychiatryBucharestSite status: Not listed — confirm with the team
Russia · 14 sites
- Kemerovo Regional Clinical Psychiatric HospitalKemerovoSite status: Not listed — confirm with the team
- Moscow Research Institute of PsychiatryMoscowSite status: Not listed — confirm with the team
- Menthal Health Research Center of the RAMSMoscowSite status: Not listed — confirm with the team
- Nizhniy Novgorod Regional Psychoneurological Hospital # 1Nizhny NovgorodSite status: Not listed — confirm with the team
- Saint-Petersburg State Public Healthcare Institution (City Psychiatric Hospital #7)Saint PetersburgSite status: Not listed — confirm with the team
- Saint-Petersburg State Public Healthcare Institution (Saint Nicholas Psychiatric Hospital)Saint PetersburgSite status: Not listed — confirm with the team
- Saint-Petersburg State Public Healthcare Institution (City Psychiatric Hospital #4)Saint PetersburgSite status: Not listed — confirm with the team
- Saint-Petersburg Research Psychoneurogical InstituteSaint PetersburgSite status: Not listed — confirm with the team
- Saint-Petersburg State Healthcare Institution (City Psychiatric Hospital #6)Saint PetersburgSite status: Not listed — confirm with the team
- Municiple Healthcare Institution (City Clinical Hospital #2)SaratovSite status: Not listed — confirm with the team
- Institution of Russian Academy of Medical SciencesTomskSite status: Not listed — confirm with the team
- Nizhny Novgorod Region State Budgetary Institution of Healthcare "Clinical Psychiatric Hospital #1 of Nizhny Novgorod"Veliky NovgorodSite status: Not listed — confirm with the team
- Yaroslavl State Medical Academy, Department of PsychiatryYaroslavlSite status: Not listed — confirm with the team
- Regional State Healthcare Institution (Sverdlovsk Regional Clinical Psychiatric Hospital)YekaterinburgSite status: Not listed — confirm with the team
Serbia · 6 sites
- Clinical Centre "Dr Dragisa Misovic", Clinic of PsychiatryBelgradeSite status: Not listed — confirm with the team
- Clinical Centre of Serbia, Clinic of PsychiatryBelgradeSite status: Not listed — confirm with the team
- Institute of Mental HealthBelgradeSite status: Not listed — confirm with the team
- Clinical Centre Nis, Psychiatric ClinicGornja ToponicaSite status: Not listed — confirm with the team
- Clinical Centre Kragujevac, Psychiatric ClinicKragujevacSite status: Not listed — confirm with the team
- Special Hospital for Psychiatric Diseases "Sveti Vracevi"VojvodinaSite status: Not listed — confirm with the team
Ukraine · 12 sites
- Crimean State Medical University (Dept. of Psychiatry)Simferopol, Autonomous Republic of CrimeaSite status: Not listed — confirm with the team
- Odesa Regional Psychiatric Hospital #2Odesa, Kominternivskyy DistrictSite status: Not listed — confirm with the team
- Dnipropetrovsk Regional Clinical HospitalDnipropetrovskSite status: Not listed — confirm with the team
- Dnipropetrovsk State Medical Academy, Dept. of PsychiatryDnipropetrovskSite status: Not listed — confirm with the team
- Donetsk National Medical University (Regional Clinical Psychiatric Hospital)DonetskSite status: Not listed — confirm with the team
- Institute of Neurology, Psychiatry and Narcology AMS of UkraineKharkivSite status: Not listed — confirm with the team
- Kharkiv Regional Clinical Psychiatric Hospital N 3KharkivSite status: Not listed — confirm with the team
- Kyiv Station Railway Clinical Hospital # 1 of the STBA "South-Western Railway"KyivSite status: Not listed — confirm with the team
- Lugansk State Medical UniversityLuhanskSite status: Not listed — confirm with the team
- Odesa Regional Psychoneurological DispensaryOdesaSite status: Not listed — confirm with the team
- Ukrainian Medical Stomatological Academy, Dept. of PsychiatryPoltavaSite status: Not listed — confirm with the team
- Vinnytsya National Medical University, Dept. of Psychiatry & NarcologyVinnytsiaSite status: Not listed — confirm with the team
United States · 22 sites
- Collaborative Neuroscience Network, IncGarden Grove, CaliforniaSite status: Not listed — confirm with the team
- Behavorial Research SpecialistsGlendale, CaliforniaSite status: Not listed — confirm with the team
- Apostle Clinical Trials, IncLong Beach, CaliforniaSite status: Not listed — confirm with the team
- Synergy Clinical Research CenterNational City, CaliforniaSite status: Not listed — confirm with the team
- Excell Research, Inc.Oceanside, CaliforniaSite status: Not listed — confirm with the team
- Neuropsychiatric Research Center of Orange CountyOrange, CaliforniaSite status: Not listed — confirm with the team
- CNRISan Diego, CaliforniaSite status: Not listed — confirm with the team
- Segal Institute for Clinical ResearchLauderhill, FloridaSite status: Not listed — confirm with the team
- Compass Research, LLCLeesburg, FloridaSite status: Not listed — confirm with the team
- Atlanta Center for Medical ResearchAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Alexian Brothers Behavioral Health HospitalHoffman Estates, IllinoisSite status: Not listed — confirm with the team
- Precise Research GroupFlowood, MississippiSite status: Not listed — confirm with the team
- St. Charles Psychiatric Associates - Midwest Reserch GroupSaint Charles, MissouriSite status: Not listed — confirm with the team
- PsychCare Consultants ResearchSt Louis, MissouriSite status: Not listed — confirm with the team
- CRI Worldwide, LLCMarlton, New JerseySite status: Not listed — confirm with the team
- Behavioral Medical ResearchBrooklyn, New YorkSite status: Not listed — confirm with the team
- Finger Lakes Clinical ResearchRochester, New YorkSite status: Not listed — confirm with the team
- Neuro-Behavorial Clinic Research, Inc.Canton, OhioSite status: Not listed — confirm with the team
- Midwest Clinical Research CenterDayton, OhioSite status: Not listed — confirm with the team
- FutureSearch Trials of Dallas, L.P.Dallas, TexasSite status: Not listed — confirm with the team
- InSite Clinical ResearchDeSoto, TexasSite status: Not listed — confirm with the team
- Houston Clinical Trials, LLCHouston, TexasSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving TC-5619, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Targacept Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01157351
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
CompletedEUCTR 2008-002247-16
A 24-month, Prospective, Randomized, Active-Controlled, Open-Label, Rater Blinded, Multicenter, International Study of the Prevention of Relapse Comparing Long-Acting Injectable Paliperidone Palmit...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
CompletedNCT01714713
EVP-6124 (Alpha-7 nAChR) for schizophrenia
This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.